Treatment and prevention of vancomycin-resistant enterococcus

被引：3

作者：

Husni, R ^{[1
]}

Raad, I ^{[1
]}

机构：

[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED SPECIALTIES,INFECT DIS SECT,HOUSTON,TX 77030

来源：

CURRENT OPINION IN INFECTIOUS DISEASES | 1997年 / 10卷 / 06期

关键词：

D O I：

10.1097/00001432-199712000-00003

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Efforts to find antimicrobial agents which are effective against vancomycin-resistant enterococcus have been unsuccessful. One promising antibiotic, quinupristin/dalfopristin, has, however, been used with a success rate of approximately 60%. Other antibiotics are under investigation. Prevention is the best policy for the control of vancomycin-resistant enterococcus and includes contact isolation, the cohorting of patients, the appropriate use of vancomycin and education of patients and staff.

引用

页码：431 / 434

页数：4

共 33 条

[1] GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].

ARTHUR, M ;

COURVALIN, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1563-1571

[2] FARM-ANIMALS AS A PUTATIVE RESERVOIR FOR VANCOMYCIN-RESISTANT ENTEROCOCCAL INFECTION IN MAN [J].

BATES, J ;

JORDENS, JZ ;

GRIFFITHS, DT .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (04) :507-514

[3] OUTBREAK OF MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH TRANSFERABLE VANB CLASS VANCOMYCIN RESISTANCE [J].

BOYCE, JM ;

OPAL, SM ;

CHOW, JW ;

ZERVOS, MJ ;

POTTERBYNOE, G ;

SHERMAN, CB ;

ROMULO, RLC ;

FORTNA, S ;

MEDEIROS, AA .

JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1148-1153

[4] ACTIVITY OF CLINAFLOXACIN AGAINST MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM [J].

BURNEY, S ;

LANDMAN, D ;

QUALE, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1668-1670

[5] COMPARISON OF DIFFERENT BETA-LACTAM-GLYCOPEPTIDE-GENTAMICIN COMBINATIONS FOR AN EXPERIMENTAL ENDOCARDITIS CAUSED BY A HIGHLY BETA-LACTAM-RESISTANT AND HIGHLY GLYCOPEPTIDE-RESISTANT ISOLATE OF ENTEROCOCCUS-FAECIUM [J].

CARON, F ;

PESTEL, M ;

KITZIS, MD ;

LEMELAND, JF ;

HUMBERT, G ;

GUTMANN, L .

JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :106-112

[6]

*CDCP, 1993, MMWR-MORBID MORTAL W, V42, P598

[7]

CHIA JKS, 1995, CLIN INFECT DIS, V21, P15

[8] Vancomycin-resistant Staphylococcus aureus: Perspectives on measures needed for control [J].

Edmond, MB ;

Wenzel, RP ;

Pasculle, AW .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (03) :329-334

[9] VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].

EDMOND, MB ;

OBER, JF ;

WEINBAUM, DL ;

PFALLER, MA ;

HWANG, T ;

SANFORD, MD ;

WENZEL, RP .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133

[10] INCONSISTENT BACTERICIDAL ACTIVITY OF TRIPLE-COMBINATION THERAPY WITH VANCOMYCIN, AMPICILLIN, AND GENTAMICIN AGAINST VANCOMYCIN-RESISTANT, HIGHLY AMPICILLIN-RESISTANT ENTEROCOCCUS-FAECIUM [J].

FRAIMOW, HS ;

VENUTI, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1563-1566

← 1 2 3 4 →